Brawn Biotech share news, announcements and annual reports
BSE: 530207Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 28 Oct 2026. Previous close ₹25.40.
28 Oct: open ₹26.64, high ₹26.64, low ₹25.87
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7.76 Cr4,925th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 9.04
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.79
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 22.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 754
Brawn Biotech has 399 announcements on record, routine notices left out; none in the 30 days to 29 Oct 2026, the latest on 29 Sep 2026.
Last results date
The last board meeting held for results; the company has not yet given notice of the next.Brawn Biotech quarterly results
The board met on 13 Aug 2026 to consider quarterly results
Notice filed 5 Aug 2026
Brawn Biotech annual reports, presentations and earnings calls
The company's own documents, latest first.Brawn Biotech financials, year by year
Annual reports24
- Annual report, year to Mar 20261 Sep 2026
- Annual report, year to Mar 20253 Sep 2025
- Annual report, year to Mar 20242 Sep 2024
- Annual report, year to Mar 20231 Sep 2023
- Annual report, year to Mar 202227 Aug 2022
19 earlier reports
- Annual report, year to Mar 20211 Sep 2021
- Annual report, year to Mar 202031 Aug 2020
- Annual report, year to Mar 20195 Sep 2019
- Annual report, year to Mar 201811 Oct 2018
- Annual report, year to Mar 201712 Oct 2017
- Annual report, year to Mar 201616 Sep 2016
- Annual report, year to Mar 201526 May 2016
- Annual report, year to Mar 201426 May 2016
- Annual report, year to Mar 201326 May 2016
- Annual report, year to Mar 201226 May 2016
- Annual report, year to Mar 2011Filing day not known
- Annual report, year to Mar 2010Filing day not known
- Annual report, year to Mar 2009Filing day not known
- Annual report, year to Mar 2008Filing day not known
- Annual report, year to Mar 2007Filing day not known
- Annual report, year to Mar 2006Filing day not known
- Annual report, year to Mar 2004Filing day not known
- Annual report, year to Mar 1999Filing day not known
- Annual report, year to Mar 1998Filing day not known
Brawn Biotech share news and announcements
Newest first. Page 1 of 8.
Sep 2026
29 Sep · Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015
29 Sep · Meeting
29 Sep · Meeting
2 Sep · Intimation W.R.T Letter Sent To Shareholders As Per Reg 36
1 Sep · Meeting
Aug 2026
5 Aug · Board meeting
Meeting on 13 Aug 2026: quarterly results
May 2026
21 May · Board meeting
Meeting on 29 May 2026: quarterly results and audited results
Mar 2026
25 Mar · Board meeting
Feb 2026
14 Feb · Results
6 Feb · Compliances-Reg. 50 (1) - Prior intimation about Board meeting under Regulation 50(1)
Jan 2026
30 Jan · Management
5 Jan · Management
Dec 2025
29 Dec · Announcement Under Regulation 30 (LODR)
22 Dec · Management
Nov 2025
14 Nov · Results
14 Nov · Results
6 Nov · Board meeting
Meeting on 14 Nov 2025: quarterly results
Sep 2025
30 Sep · Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('SEBI Listing Regulations')
30 Sep · Meeting
4 Sep · Intimation W.R.T Letter Sent To Shareholders As Per Reg 36
2 Sep · Announcement Under Regulation 30
2 Sep · Board meeting
Aug 2025
6 Aug · Board meeting
Meeting on 13 Aug 2025: quarterly results
May 2025
28 May · AFR For The Qtr/Year Ended 31St March 2025
26 May · AFR For The Quarter/ Year Ended 31/03/2025
26 May · Board meeting
16 May · Board meeting
Meeting on 26 May 2025: audited results
Feb 2025
14 Feb · Results
How the price met the news
The first session after each announcement, beside the market.
That dayThe first session's move. The first session's close after the announcement against the close before it, as a per cent change, on prices adjusted for splits and bonuses.Against the Nifty 500Against the Nifty 500. The share's move less the Nifty 500's move the same session, in percentage points (pts).Market median on that newsThe market's median move on that news. The middle first-session move of every listed company that filed the same kind of announcement, half moving more and half less.Five sessionsFive sessions' move. The close five sessions after the announcement against the close before it, as a per cent change.Five sessions against the Nifty 500Five sessions against the Nifty 500. The share's five-session move less the Nifty 500's move over the same five sessions, in percentage points (pts).Volume, times usualVolume, times usual. The session's shares traded divided by the average of the twenty sessions before it.
- 30 Jan 2026Board or managers changedup 4.96%+5.2 pts vs Nifty 500market median 0.0% · five sessions −4.4% (−5.6 pts vs Nifty 500) · volume 5.3× usual · The announcement
- 7 Jan 2026Board or managers changedup 4.85%+5.0 pts vs Nifty 500market median 0.0% · five sessions +15.8% (+18.2 pts vs Nifty 500) · volume 0.1× usual · The announcement
- 23 Dec 2025Board or managers changed0.00%−0.1 pts vs Nifty 500market median 0.0% · five sessions −7.2% (−7.4 pts vs Nifty 500) · volume 1.7× usual · The announcement
- 26 Nov 2025Board or managers changeddown 4.74%−6.0 pts vs Nifty 500market median 0.0% · five sessions −11.6% (−11.9 pts vs Nifty 500) · volume 10.4× usual · The announcement
- 29 Aug 2024Board or managers changedup 4.97%+4.9 pts vs Nifty 500market median 0.0% · five sessions −3.0% (−3.6 pts vs Nifty 500) · volume 3.2× usual · The announcement
- 28 Aug 2024Board or managers changeddown 0.50%−0.6 pts vs Nifty 500market median 0.0% · five sessions −4.1% (−4.9 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 28 Jul 2022Board or managers changedup 2.01%+0.6 pts vs Nifty 500market median 0.0% · five sessions +8.1% (+3.7 pts vs Nifty 500) · volume 0.0× usual · The announcement
- 22 Oct 2020Board or managers changedup 4.84%+5.0 pts vs Nifty 500market median 0.0% · five sessions −3.2% (−2.0 pts vs Nifty 500) · volume 1.1× usual · The announcement
- 7 Oct 2019Board or managers changeddown 0.36%+0.2 pts vs Nifty 500market median 0.0% · five sessions −4.8% (−5.9 pts vs Nifty 500) · volume 0.7× usual · The announcement
- 6 Nov 2018Board or managers changeddown 1.28%−1.0 pts vs Nifty 500market median 0.0% · five sessions −2.2% (−2.5 pts vs Nifty 500) · volume 0.2× usual · The announcement
7 earlier announcements
- 30 May 2018Dividendup 1.70%+1.9 pts vs Nifty 500market median 0.0% · five sessions −12.8% (−11.1 pts vs Nifty 500) · volume 0.9× usual · The announcement
- 16 Aug 2017Dividendup 0.88%−0.2 pts vs Nifty 500market median 0.0% · five sessions −10.4% (−9.9 pts vs Nifty 500) · volume 1.4× usual · The announcement
- 30 May 2017Dividendup 4.98%+4.6 pts vs Nifty 500market median 0.0% · five sessions −1.1% (−2.7 pts vs Nifty 500) · volume 1.5× usual · The announcement
- 10 Jan 2017Board or managers changedup 5.00%+4.3 pts vs Nifty 500market median 0.0% · five sessions +0.3% (−2.0 pts vs Nifty 500) · volume 2.9× usual · The announcement
- 8 Aug 2016Dividenddown 4.95%−5.4 pts vs Nifty 500market median 0.0% · five sessions −13.5% (−13.3 pts vs Nifty 500) · volume 0.5× usual
- 30 May 2016Dividenddown 4.98%−5.3 pts vs Nifty 500market median 0.0% · five sessions −19.3% (−20.0 pts vs Nifty 500) · volume 3.1× usual
- 26 May 2016Dividendup 5.00%+3.5 pts vs Nifty 500market median 0.0% · five sessions −8.3% (−11.1 pts vs Nifty 500) · volume 1.0× usual